Page last updated: 2024-10-25

debrisoquin and Balkan Endemic Nephropathy

debrisoquin has been researched along with Balkan Endemic Nephropathy in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mantle, PG1
Amirtharajah, M1
Klippel, S1
Miljkovic, A1
Naik, JT1
Nestler, S1
Nikolov, IG1
Chernozemsky, IN1
Idle, JR1

Other Studies

2 other studies available for debrisoquin and Balkan Endemic Nephropathy

ArticleYear
Debrisoquine 4-hydroxylation and the Balkan endemic nephropathy.
    Nephron, 1999, Volume: 81, Issue:3

    Topics: Animals; Balkan Nephropathy; Crosses, Genetic; Debrisoquin; Diet; Disease Models, Animal; Female; Fo

1999
Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor.
    IARC scientific publications, 1991, Issue:115

    Topics: Adult; Aged; Balkan Nephropathy; Bulgaria; Carcinoma, Transitional Cell; Case-Control Studies; Cytoc

1991
chemdatabank.com